Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer

This transnational noninterventional study aims to gather real-world evidence on locally recurrent inoperable (hereafter referred to as advanced) or metastatic TNBC (a/m TNBC) biomarker testing, treatment patterns by line of therapy, and outcomes to contextualize findings of TROPION-Breast02 and TROPION-Breast05 in selected settings outside the United States (US), including Canada, the United Kingdom (UK), France, and Spain.

NCT Number	NCT07092254
Lead Sponsor	Daiichi Sankyo
Conditions	Triple Negative Breast Cancer
Enrollment	760 participants
Start Date	2025-09-01
Primary Completion	2025-11-28 (estimated)
Study Completion	2026-09-04 (estimated)
Updated on ClinicalTrials.gov	2026-06-17